Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948050 · ClinicalTrials.gov registry record · NA
Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients
A NA study, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01948050 is a NA study that has completed, run by Beth Israel Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT01948050, a NA study, has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS) to relieve pain in cancer patients who developed neuropathic pain in the affected area after a surgical intervention, radiation therapy, or chemotherapy to treat the disease.
Interventions
- DEVICE non-invasive transcranial direct current stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948050
The ClinicalTrials.gov registry entry for NCT01948050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which non-invasive transcranial direct current stimulation (tDCS) is the first listed.
NCT01948050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948050 about?
NCT01948050 is a clinical study titled "Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients". This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS) to relieve pain in cancer patients who developed neuropathic pain in the affected area after a surgical intervention, radiation therapy, or chemotherapy to treat the di...
What is the current status of trial NCT01948050?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2009-01. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01948050?
The interventions under investigation include: non-invasive transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT01948050?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.